Objectives: Our objective was to assess the clinical usefulness of the Nociception Coma Scale-revised (NCS-R) in pain management of patients with disorders of consciousness.
P
ain management in patients with disorders of consciousness (DOC) such as vegetative/unresponsive wakefulness syndrome (VS/UWS; characterized by the presence of arousal and the absence of consciousness 1 ) or minimally conscious state (MCS; characterized by the presence of fluctuating but reproducible oriented/voluntary responses without functional communication 2 ) remains challenging, the assessment being limited by the absence of communication and subjective report. The difficulties in treating pain in those patients lead to evident ethical and medical concerns. In acute as in chronic stages, several conditions such as polytraumatic injuries, open wounds, spasticity, arthralgia, ankylosis, tendon retraction, or peripheral injuries are likely to induce pain, especially during care and mobilization. 3, 4 Several neuroimaging studies on pain processing in this population suggest that MCS and some VS/UWS patients would be able to perceive pain even if they cannot express it. 5, 6 Indeed, these studies reported brain activation in areas involved in the cognitive and emotional processing of pain (such as the anterior cingulate cortex) after a noxious stimulation in a group of MCS and in around 30% of VS/ UWS patients. These findings suggest that patients with DOC may retrieve pain perception and support the idea that those patients need analgesic treatment and monitoring. To improve pain management in severely brain-injured patients, we need sensitive clinical tools to adequately monitor analgesic treatment. Indeed, an underuse of analgesics is not desired, whereas an overuse of analgesics in DOC could lead to drowsiness and subsequent underestimation of signs of consciousness.
In the absence of pain assessment tools, a new scale was specifically developed for patients with DOC, the Nociception Coma Scale (NCS). 7 This scale was developed on the basis of preexisting pain scales developed for noncommunicative patients with advanced dementia 8 and newborns. 9 It has shown very good psychometric properties (ie, concurrent validity, test-retest reliability, and inter-rater agreement) [10] [11] [12] and its revised version (NCS-R) has demonstrated high sensitivity in assessing responses to acute nociceptive pain with a defined cut-off score of 4 (with a sensitivity of 73% and specificity of 97%) for detecting and, potentially, treating pain in severely brain-injured patients. 10 Finally, a recent neuroimaging study has investigated whether the NCS-R was related to brain areas involved in the so-called pain matrix. 13 Using 18-fluoro-deoxyglucose positron-emission tomography scan, a significant correlation was found between NCS-R total scores and brain metabolism in the anterior cingulate cortex, suggesting that the NCS-R is related to pain processing.
Together, the findings described suggest that the NCS-R may constitute an appropriate behavioral tool to assess, monitor, and treat nociception and pain in noncommunicative patients with DOC. Previous studies have investigated the interest of the scale for pain management using experimental pain but not using clinical pain. In this study, we assessed the clinical usefulness of the NCS-R in the pain management of patients with DOC. We used the NCS-R to investigate the response to analgesic in patients with documented potential pain during clinical cares. We hypothesized that the NCS-R total scores and subscores would decrease during analgesic treatment versus before treatment. In addition, we expected that a good balance between analgesics and optimal level of consciousness would be illustrated by an absence of difference in the scores of the Glasgow Coma Scale (GCS) during treatment versus before treatment (Table 1) .
MATERIALS AND METHODS

Participants
This is a prospective study including patients from the intensive care and the neurology units of the University Hospital of Charleroi. Inclusion criteria were: (1) age above 18 years old; (2) no administration of neuromuscular blockers or sedation within the 24 hours of enrollment; (3) a diagnosis of VS/UWS or MCS, based on behavioral assessment performed using the GCS; and (4) the presence of potential pain during care (based on the medical record). Exclusion criteria were: (1) documented history of prior brain injury; (2) premorbid history of developmental, psychiatric, or neurological illness resulting in documented functional disability up to time of the injury; and (4) intubation. The study was approved by the Ethics Committee of the University Hospital of Charleroi and a written informed consent was obtained from the patients' legal representative.
Procedure
The NCS-R consists of 3 subscales assessing motor, verbal, and facial expression responses; each subscore ranges from 0 to 3 (total score: 0 to 9, Table 1 ). The scale was only administered by nurses trained following a 2-hour seminar including video scoring (led by C.C.). When a patient who presented a documented potential pain showed a score of 4 or more during nursing cares, the nurses discussed with the physician in charge the possibility of an analgesic treatment (either the introduction of an analgesic or a change in the medication/dosage). The patient was then reassessed after the administration of an analgesic treatment tailored to his/her clinical status. The 2 assessments had to be performed in the same condition (ie, nursing cares, same rater) within 24 hours to limit fluctuations in the patients' medical status. The highest score obtained within each subscale during the assessment were summed to obtain a total score. 10 In addition to the NCS-R, the GCS 14 was used before and during treatment to observe fluctuations in consciousness. The GCS is widely used to assess consciousness in acute settings. 15 It consists of 3 subscales assessing eye opening, motor, and verbal responses, the total score ranges from 3 to 15.
Statistical Analyses
As our data (ie, NCS-R total scores and subscores as well as the GCS total scores) were not normally distributed according to Shapiro-Wilk tests (W < 1), we performed nonparametric Wilcoxon tests to investigate the difference in the NCS-R total scores and in the GCS total scores but also in the NCS-R subscores before versus during treatment. In addition, using a Mann-Whitney U test, we assessed the effect of the level of consciousness (VS/UWS vs. MCS) and the etiology (traumatic vs. nontraumatic) on the differences (ie, subtraction) of scores before versus during treatment. Analyses were performed using SPSS (version 20) and were considered significant at P < 0.05.
RESULTS
Fifty-nine patients with DOC were assessed for the study (see Fig. 1 for study flow chart). Seventy-six percent of our sample (45 of 59 patients) presented documented potential pain ( Fig. 1 for study flow chart) . Thirty-nine patients of the 59 patients with potential painful areas (eg, due to fractures, decubitus ulcers, or spasticity) were included in the study (Table 2) . Of these 39 patients, 59% of the patients (23 of 39) did not have any analgesic treatment before the assessment. Twelve patients were in a VS/UWS (9 males; age range: 22 to 90 y; 0 to 108 d after injury; 10 nontraumatic) and 27 were in a MCS (20 males; age range: 21 to 93 y; 0 to 4380 d after injury; 15 nontraumatic). Of the 39 patients included, 23 had no analgesic treatment before the assessment, whereas the analgesic treatment has been revised in the other 16 patients.
For the NCS-R, the total scores (5.2 ± 1.3 vs. 3.7 ± 1.9; z = 4.37; P < 0.0001), the motor subscores (2 ± 0.7 vs. 1.5 ± 0.9; z = 3.09; P = 0.002), the verbal subscores (1.2 ± 1.1 vs. 1 ± 1; z = 2.22; P = 0.027), and the facial expression subscores (2 ± 0.5 vs. 1.2 ± 0.9; z = 3.92; P < 0.0001), were lower during treatment than before treatment (Figs. 2, 3) . We did not find any effect of treatment on the GCS total scores (8.8 ± 2.4 vs. 8.8 ± 2.6; z = 0.2; P = 0.98, Fig. 2 ). The Mann-Whitney U test analyses did not show any effect of the level of consciousness or etiology. Table 3 represents the frequencies for decrease, increase, or no change in NCS-R total scores versus decrease, increase, or no change in GCS total scores. Twenty-five patients presented a decrease in NCS-R total scores, of whom 20 patients did not present a decrease in GCS total scores. From the remaining patients, 12 did not show a decrease in NCS-R scores and 2 showed an increase after treatment. For 31 patients, no change in the GCS scores (22) or an increase in the scores (9) was observed after treatment.
DISCUSSION
Pain management in patients with DOC is a challenge, due both to the absence of communication and subjective report. The NCS-R 10 has recently been introduced to assess pain in this population. In the present study, we According to our results, the NCS-R total scores and subscores decreased substantially during analgesic treatment in severely brain-injured patients with documented painful areas, suggesting that the scale is a good tool to manage pain in this population. In addition, the decrease of NCS-R total scores was not different according to the etiology or the level of consciousness suggesting that the scale can be used in a broad population of patients with DOC (ie, traumatic or nontraumatic and VS/UWS or MCS patients).
In our study, the decrease in the NCS-R scores was not associated with a decrease in the GCS total scores during analgesic treatment, suggesting that the NCS-R may be useful when a balance needs to be found between reduced pain and preserved level of consciousness. More precisely, a good balance could be obtained in 20 patients, showing a decrease in the NCS-R scores with no decrease of the level of consciousness (ie, GCS scores) at the single level. This is of real interest for clinicians, as an underuse of analgesics is not desired, whereas an overuse of analgesics could lead to drowsiness and subsequent underestimation of signs of consciousness in these patients. It is also important to note that 5 of the 20 patients showed higher signs of consciousness (ie, increase in GCS scores) after the analgesic treatment as compared with before, suggesting that the presence of pain may have compromised the ability of the patient to respond at bedside. A recent study also found an improvement of consciousness when administering analgesic treatment to a patient with severe brain injury with severe spasticity. 16 Such a result is not that surprising. Patients in a MCS usually present limited attentional resources. The presence of pain could reduce these resources even more, and prevent the patient from interacting with his surroundings and showing any sign of consciousness.
The fact that 76% of our sample presented documented potential pain, whereas 59% of the patients included in this study did not have any analgesic treatment before the assessment underlines the crucial need for an appropriate management of pain in this population. A recent study showed that a large portion of chronic patients with severe brain injury (67%) have spasticity and that its severity is associated to the NCS-R total scores, comforting further the need to detect and treat documented painful areas in this population. 4 Our study have limitations to consider. Firstly, patients were assessed after a single administration of analgesic tailored to the patient. Future studies should look at the effect of different analgesic and dosages on NCS-R scores and level of consciousness to further investigate the NCS-R sensitivity to various pain treatment. Secondly, the GCS was used to assess the patients' level of consciousness. Although the scale is useful for detecting a recovery from coma, it is less sensitive to detect subtle signs of consciousness. 17 The use of the Coma Recovery Scale-revised would be more appropriate to capture a decrease of the level of consciousness after analgesic intake as it is one of the most validated and sensitive behavioral scales currently available. 18 The GCS was nevertheless chosen because it was already implemented in the setting in which the study took place. One could criticize that the study design as assessments were performed by different raters. However, the inter-rater reliability of the scale has been shown to be good in a series of previous studies, the background of the raters was the same (all nurses) and the level of experience has been found as not impacting the scoring in a previous study. 11 Another limitation is the score of 4 used as a threshold for determining the presence of pain. In our sample, 3 patients with potential pain (and no analgesic treatment) showed a score of r3, and were therefore excluded from the study. The use of a cut-off score was based on a previous study which showed a differentiation between nonpainful and painful stimulation at a score of 4 with a sensitivity of 73% and a specificity of 97%. This threshold will nevertheless need to be confirmed in future clinical studies, as it may differ according to the patient's level of consciousness. 10 Besides, one could argue that, even though painful areas were not documented in 14 patients, they could have been in pain. In the context of this study, including patients with known potential pain was easier for showing the clinical validity of the NCS-R. Future studies could nevertheless investigate the presence of target behaviors (eg, grimaces) in the detection and treatment of pain. The majority of the patients enrolled were in acute stage (ie, 33 patients assessed <28 d after injury), therefore we could not investigate the effect of the chronicity or take into account pain condition that may appear at a more chronic stage (eg, spasticity). One could also argue that the level of consciousness of acute patients may change rapidly and that they may have recovered consciousness on the second assessment. However, as we assessed the patients' level of consciousness at the same time as the pain assessment during cares, the likelihood that these patients were not in disorders of consciousness at the time of the assessment is inexistent. This is a first study highlighting the interest of the NCS-R for clinical setting, it would be useful to compare changes in the NCS-R when analgesics are administered in a double-blind placebo-control study, to control that the observed changes were only associated with analgesic treatment. Finally, 14 patients did not show a decrease in the NCS-R and 11 of them did not show a decrease at the GCS either, highlighting the current need for a better understanding of response to analgesic treatment in this population for short-term and long-term pain management.
In conclusion, our results suggest that the NCS-R is an interesting clinical tool for the management of pain in noncommunicative patients with DOC. We would suggest the use of this scale for a daily monitoring of severely brain-injured patients' pain during cares. Further studies will be needed to develop clear guidelines regarding the management of pain and nociception in this population as those are currently nonexistent.
